Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
**Background:** Few studies have estimated the real-world economic burden such as all-cause and follicular lymphoma-related costs and health care resource utilization (HCRU) in patients with follicular lymphoma (FL). **Objectives:** This study evaluated outcomes in patients who were newly initiate...
Saved in:
Main Authors: | Nathan H. Fowler, Guifang Chen, Stephen Lim, Stephanie Manson, Qiufei Ma, Frank Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2020-09-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/jheor.2020.16784 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
by: Scott F. Huntington, et al.
Published: (2022-10-01) -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01) -
Connexin 43 Communication Channels in Follicular Dendritic Cell Development and in Follicular Lymphomas
by: Hajnalka Rajnai, et al.
Published: (2015-01-01) -
Follicular Lymphoma In Situ Presenting as Dermatopathic Lymphadenopathy
by: Orah Nnamdi Obumneme, et al.
Published: (2013-01-01) -
A Case of Chyloperitoneum Secondary to Follicular Lymphoma and a Review of Prognostic Implications
by: Megan Jagosky, et al.
Published: (2016-01-01)